Next generation vaccines represent a leap forward in vaccine technology, utilizing advances in molecular biology, immunology, and biotechnology. Unlike traditional vaccines, which often use inactivated or attenuated pathogens, these new vaccines can be designed using recombinant DNA, mRNA, vector-based platforms, and other novel methods. This approach allows for greater specificity, efficacy, and safety.
